Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress
暂无分享,去创建一个
T. Murohara | X. Cheng | A. Inoue | M. Kuzuya | G. Shi | Takeshi Sasaki | Kae Nakamura | Weon Kim | Xueling Yue | Zhe Huang | Xiangkun Meng | Hailong Wang | Limei Piao | Shengnan Xu | Ying Wan
[1] Ji Sun Kim,et al. Psychological distress of patients with end-stage kidney disease undergoing dialysis during the 2019 coronavirus disease pandemic: A cross-sectional study in a University Hospital , 2021, PloS one.
[2] X. Cheng,et al. Role of Dipeptidyl Peptidase-4 in Atherosclerotic Cardiovascular Disease in Humans and Animals with Chronic Stress. , 2021, International heart journal.
[3] Jianzhong Lu,et al. Calcium-sensing receptor promotes calcium oxalate crystal adhesion and renal injury in Wistar rats by promoting ROS production and subsequent regulation of PS ectropion, OPN, KIM-1, and ERK expression , 2021, Renal failure.
[4] M. Sims,et al. Association between goal-striving stress and rapid kidney function decline among African Americans: the Jackson Heart Study , 2020, Journal of Investigative Medicine.
[5] A. Garg,et al. Biomarkers of inflammation and repair in kidney disease progression. , 2020, The Journal of clinical investigation.
[6] G. Metz,et al. Cardiorenal metabolic biomarkers link early life stress to risk of non-communicable diseases and adverse mental health outcomes , 2020, Scientific Reports.
[7] Yuting Liu,et al. ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway , 2020, Cell Death & Disease.
[8] X. Cheng,et al. Increased dipeptidyl peptidase-4 accelerates chronic stress-related thrombosis in a mouse carotid artery model. , 2020, Journal of hypertension.
[9] T. Murohara,et al. Deficiency of cysteinyl cathepsin K suppresses the development of experimental intimal hyperplasia in response to chronic stress. , 2020, Journal of hypertension.
[10] K. Okumura,et al. PLF‐1 (Proliferin‐1) Modulates Smooth Muscle Cell Proliferation and Development of Experimental Intimal Hyperplasia , 2019, Journal of the American Heart Association.
[11] L. Lanfumey,et al. Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity , 2019, Nature Medicine.
[12] P. Libby,et al. Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis , 2019, iScience.
[13] L. Smeeth,et al. Cross-sectional study of association between psychosocial stressors with chronic kidney disease among migrant and non-migrant Ghanaians living in Europe and Ghana: the RODAM study , 2019, BMJ Open.
[14] G. Parati,et al. Neuroimmune crosstalk in the pathophysiology of hypertension , 2019, Nature Reviews Cardiology.
[15] T. Murohara,et al. Cathepsin S Deficiency Mitigated Chronic Stress–Related Neointimal Hyperplasia in Mice , 2019, Journal of the American Heart Association.
[16] P. Libby,et al. Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction. , 2019, Journal of molecular and cellular cardiology.
[17] M. Sims,et al. Goal-Striving Stress Is Associated with Chronic Kidney Disease Among Participants in the Jackson Heart Study , 2019, Journal of Racial and Ethnic Health Disparities.
[18] P. Libby,et al. Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials , 2018, Nature Reviews Cardiology.
[19] H. Krum,et al. Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome , 2017, PloS one.
[20] K. Okumura,et al. Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia‐Induced Neovascularization: The Role of Dipeptidyl Peptidase‐4/Glucagon‐Like Peptide‐1‐Adiponectin Axis , 2017, Journal of the American Heart Association.
[21] K. Okumura,et al. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress. , 2017, International journal of cardiology.
[22] K. Okumura,et al. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress. , 2017, Atherosclerosis.
[23] M. Runge,et al. NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis. , 2017, Journal of molecular and cellular cardiology.
[24] K. Krause,et al. NADPH oxidase 4 deficiency increases tubular cell death during acute ischemic reperfusion injury , 2016, Scientific Reports.
[25] T. Murohara,et al. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K−Akt/p-HDAC6 Signaling Pathway , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[26] Johan Kuiper,et al. Acute and chronic psychological stress as risk factors for cardiovascular disease: Insights gained from epidemiological, clinical and experimental studies , 2015, Brain, Behavior, and Immunity.
[27] Kumar Sharma,et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.
[28] K. Okumura,et al. Cathepsin K-mediated notch1 activation contributes to neovascularization in response to hypoxia , 2014, Nature Communications.
[29] K. Okumura,et al. Cathepsin K Activity Controls Injury-Related Vascular Repair in Mice , 2014, Hypertension.
[30] M. Hayashi,et al. Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients , 2014, Heart and Vessels.
[31] Chao-ke Tang,et al. Psychological stress, immune response, and atherosclerosis. , 2012, Atherosclerosis.
[32] K. Okumura,et al. Role for Cysteine Protease Cathepsins in Heart Disease: Focus on Biology and Mechanisms With Clinical Implication , 2012, Circulation.
[33] K. Okumura,et al. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. , 2011, Hypertension.
[34] K. Okumura,et al. Angiotensin Type 1 Receptor Blocker Reduces Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice , 2011, Hypertension.
[35] K. Okumura,et al. Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin , 2011, Journal of hypertension.
[36] Michael C. Ostrowski,et al. Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K , 2009, Circulation research.
[37] F. Dhabhar. Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection versus Immunopathology , 2008, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[38] J. Kiecolt-Glaser,et al. Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.
[39] B. Kasiske,et al. Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure , 1988, Circulation research.